Immunotherapies to modulate immunosuppression by TGF-ß1 in cancer or graft-versus-host disease
(2022) FASEB SRC: TGFB superfamily: Signaling in Development and Disease 2022 — Location: Malahide, Ireland (17.July.2022)
Files
No attached file found for this publication.
Details
- Authors
- Abstract
- Cancellation for personal reasons
- Affiliations
Citations
Lucas, S. (2022). Immunotherapies to modulate immunosuppression by TGF-ß1 in cancer or graft-versus-host disease. FASEB SRC: TGFB superfamily: Signaling in Development and Disease 2022, Malahide, Ireland. https://hdl.handle.net/2078.5/215428